BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Guerrero W, Munene G, Dickson PV, Stiles ZE, Mays J, Davidoff AM, Glazer ES, Shibata D, Deneve JL. Outcome and factors associated with aborted cytoreduction for peritoneal carcinomatosis. J Gastrointest Oncol 2018;9:664-73. [PMID: 30151262 DOI: 10.21037/jgo.2018.04.05] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Baron E, Gushchin V, Sittig M, Sardi A. ASO Author Reflections: When Laboratories Could Help Avoid Unnecessary Surgery. Ann Surg Oncol 2020;27:2557-8. [PMID: 32189168 DOI: 10.1245/s10434-020-08313-z] [Reference Citation Analysis]
2 Sarkar A, Lansom J, Dey A, Fisher O, Alzahrani N, Morris DL. Outcomes in cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for maximal volume (PCI 39) appendiceal tumours. Eur J Surg Oncol 2021;47:1406-10. [PMID: 33279358 DOI: 10.1016/j.ejso.2020.11.138] [Reference Citation Analysis]
3 Carboni F, Federici O, Giofrè M, Valle M. An 18-Year Experience in Diagnostic Laparoscopy of Peritoneal Carcinomatosis: Results from 744 Patients. J Gastrointest Surg 2020;24:2096-103. [DOI: 10.1007/s11605-019-04368-w] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
4 Wang CC, Wagar MK, Godecker A, Al-niaimi A, Kushner DM. When we open and close: Postoperative outcomes after aborted primary cytoreduction for ovarian cancer. Gynecologic Oncology Reports 2022;41:100981. [DOI: 10.1016/j.gore.2022.100981] [Reference Citation Analysis]
5 Follette C, Liebscher S, Mouw T, Al-kasspooles M. Hyperthermic Intraperitoneal Chemotherapy (HIPEC) and Cytoreductive Surgery (CRS) for Colorectal Cancer: Potential for Individualized Care, Review of Current Treatment Trends, Recent Advancements, and a Look into the Future. Curr Colorectal Cancer Rep 2019;15:36-44. [DOI: 10.1007/s11888-019-00427-1] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
6 Baron E, Milovanov V, Gushchin V, Sittig M, Neiroda C, Sardi A. Predicting Aborted Hyperthermic Intraperitoneal Chemotherapy (AHIPEC) with Preoperative Tumor and Inflammatory Markers in Potentially Resectable Appendiceal Cancer Patients with Peritoneal Carcinomatosis. Ann Surg Oncol 2020;27:2548-56. [DOI: 10.1245/s10434-019-08117-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Marulanda K, Maduekwe UN. Disparities in the Management of Peritoneal Surface Malignancies. Surg Oncol Clin N Am 2022;31:29-41. [PMID: 34776062 DOI: 10.1016/j.soc.2021.07.005] [Reference Citation Analysis]
8 Shaltiel T, Solomon D, Pletcher ER, Golas BJ, Magge DR, Sarpel U, Labow DM, Cohen NA. Laparoscopic cytoreductive surgery and hyperthermic intraperitoneal chemotherapy is associated with improved perioperative outcomes: a single-center early experience propensity-matched analysis. Surg Endosc 2022. [PMID: 35080674 DOI: 10.1007/s00464-022-09034-y] [Reference Citation Analysis]